Ecotoxicity and carbon footprint of commonly used antibiotics: Moving towards environmentally sustainable use - 19/11/26
, Valérie Pierre c, Anne-Lise Beaumont b, d, e, Sébastien Taillemite f, Nicolas Nyssen f, Fréderic Bounoure g, h, i, Céline Bougle i, Véronique Mondain b, j, k, Emmanuel Piednoir a, l, Didier Hocquet k, mAbstract |
Introduction |
The environmental impact of antibiotics is described as high, although it has never been precisely assessed. We evaluated the environmental impact of some antibiotics.
Methods |
Environmental impact was measured by ( i ) carbon footprint (CF) through Life Cycle Assessment and ( ii ) ecotoxicity, assessed by the Risk Quotients for the risk of antimicrobial resistance development (RQ-R), calculated from median environmental concentrations and theoretical Predicted No-Effect Concentrations (PNECs).
Results |
Production of antibiotics in Europe reduces CF compared to production in Asia. Intravenous (IV) levofloxacin has a higher CF than per os levofloxacin. IV push has a lower CF than IV drip administration. Ceftriaxone and azithromycin have respectively a lower CF than cefotaxime and clarithromycin. Although co-trimoxazole CF is higher than that of fluoroquinolones, its RQ-R is lower.
Conclusion |
Although discrepancies between CF and eco-toxicity limit recommendations, these two parameters may guide decisions to reduce environmental footprint in a One-Health approach.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Highlights |
• | Producing an antibiotic in Europe reduces carbon footprint (CF) when compared to producing it in Asia. |
• | Levofloxacin administered intravenously (IV) has a higher carbon footprint than per os administration. |
• | IV push of ceftriaxone has a lower CF than IV drip administration. |
• | The Defined Daily Dose is the main driver of a treatment’s CF: ceftriaxone have a lower CF than cefotaxime. |
• | CF and eco-toxicity may guide decisions to reduce environmental footprint in a One-Health approach. |
Keywords : Environmental footprint, Carbon footprint, ecotoxicity, antibiotics, One Health
Plan
Vol 56 - N° 8
Article 105354- novembre 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
